Healthcare

Request for TOC Request for Sample
BUY NOW

Global Coronary Stents Market - Industry Trends and Forecast to 2028

Healthcare | Upcoming Report | Mar 2021 | Global | 350 Pages | No of Tables: 60 | No of Figures: 220

Report Description

Global Coronary Stents Market, By Type (Dual Therapy Stent, Bioabsorbable Vascular Scaffold, Drug Eluting Stent (DES), Bio-Engineered Stent and Bare Metal Stent), Absorption Rate (Slow-Absorption DES and Fast-Absorption (DES)), Material (Stainless Steel, Cobalt Alloy Metal, Gold, Tantalum, Nitino and Polymers), Rate (Slow-Absorption Stents and Fast-Absorption Stents), Application (Coronary Artery Disease and Peripheral Artery Disease), Mode Of Delivery (Balloon-expandable Stents and Self-expanding Stents), End Users (Hospitals, Cardiac Centres and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Get Exclusive Sample Copy of this Report Here

Market Analysis and Insights of Coronary Stents Market

Rise in the prevalence of angioplasty surgeries coupled with the rising geriatric population is promoting the coronary stents market value. Data Bridge Market Research analyses that the coronary stents market will exhibit a CAGR of around 7.34% for the forecast period of 2021-2028.

Coronary stents are the expandable mesh tubes that are inserted into the coronary arteries to regulate to flow or the supply of blood. It is used during a surgical process to keep the arteries open and prevent them from getting blood clogged. The coronary stents are made of medical-grade steel and once inserted, stay in the arteries permanently. This is because the tissues will start to coat the stent-like layer of the skin itself. Coronary stents are used in almost every angioplasty nowadays.

With the rising number of patients with heart-related diseases, the demand for coronary stents has significantly gone up. The rising geriatric population coupled with rising cardiovascular diseases and diabetic patients have led to the rise in demand for coronary stents. The low rate of risks involved coupled with the low cost of manufacturing has also propelled the demand for coronary stents.

Complications involved in the insertion of a stent will slow down the rate of market growth. The high cost of undergoing the procedure of implantation will further restrict the scope of growth. The recent coronavirus outbreak has also negatively impacted the market.

This coronary stents market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on coronary stents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Coronary Stents Market Scope and Market Size

The coronary stents market is segmented on the basis of type, absorption rate, material, rate, application, mode of delivery and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of type, the coronary stents market is segmented into dual therapy stent, bioabsorbable vascular scaffold, drug eluting stent (DES), bio-engineered stent and bare metal steel. Drug Eluting Stent (DES) is further sub-segmented into paclitaxel and limus-based drugs.
  • On the basis of absorption rate, the coronary stents market is segmented into slow-absorption DES and fast-absorption DES.
  • On the basis of material, the coronary stents market is segmented into stainless steel, cobalt alloy metal, gold, tantalum, nitino and polymers.
  • On the basis of rate, the coronary stents market is segmented into slow absorption stents and fast-absorption stents.
  • The coronary stents market is also segmented on the basis of application into coronary artery disease and peripheral artery disease.
  • On the basis of mode of delivery, the coronary stents market is segmented into balloon-expandable stents and self-expanding stents.
  • The market is also segmented on the basis of end users into hospitals, cardiac centres and others.

Coronary Stents Market Country Level Analysis

The coronary stents market is analysed and market size insights and trends are provided by country, type, absorption rate, material, rate, application, mode of delivery and end users as referenced above.

The countries covered in the coronary stents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the coronary stents market owing to the growing prevalence of cardiovascular diseases. Also, good level of healthcare infrastructure coupled with the increased research and development proficiencies have fostered the growth of the market in this region. Asia-Pacific on the contrary will exhibit the highest growth rate during the forecast period owing to the rising angioplasty surgeries in this region. Rising diabetic patients coupled with bad lifestyle choices such as drinking and smoking have also bolstered the market growth.

The country section of the coronary stents market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Coronary Stents Market Share Analysis

The coronary stents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to coronary stents market.

The major players covered in the coronary stents market report are Medtronic, Abbott., Boston Scientific Corporation or its affiliates., BIOTRONIK SE & Co KG, B. Braun Melsungen AG, Terumo Corporation, STENTYS SA, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concept., W. L. Gore & Associates, Inc., BD., ENDOLOGIX LLC., Translumina., JOTEC GmbH, Lombard Medical, Xcell Medical Group, Cardinal Health., Cook and Sahajanand Laser Technology Limited (SLTL Group) among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Table of Content

1. INTRODUCTION

       1.1. OVERVIEW OF THE GLOBAL CORONARY STENTS MARKET
       1.2. MARKET SEGMENTATION & COVERAGE
                1.2.1. CURRENCY AND PRICING 
                1.2.2. LIMITATION
                1.2.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

       2.1. KEY TAKEAWAYS
       2.2. ARRIVING AT THE GLOBAL CORONARY STENTS MARKET SIZE
                2.2.1. MARKET CRACKDOWN APPROACH 
                2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
                2.2.3. DATA TRIANGULATION
                2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
                2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
                2.2.6. PORTER’S FIVE FORCES MATRIX
       2.3. GLOBAL CORONARY STENTS MARKET: RESEARCH SNAPSHOT
       2.4. ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

       4.1. OVERVIEW
       4.2. GLOBAL CORONARY STENTS MARKET: KEY PRIMARY INSIGHTS
       4.3. MARKET OVERVIEW
                4.3.1. DRIVERS
                4.3.2. RESTRAINTS
                4.3.3. OPPOTUNITIES
                4.3.4. THREATS
       4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. GLOBAL CORONARY STENTS MARKET, BY TYPE

       5.1. OVERVIEW
       5.2. DUAL THERAPY STENT
       5.3. BIORESORBABLE VASCULAR SCAFFOLD
       5.4. DRUG ELUTING STENT (DES)
                5.4.1. PACLITAXEL
                5.4.2. IMUS-BASED DRUGS
       5.5. BIO-ENGINEERED STENT
       5.6. BARE METAL STENT

6. GLOBAL CORONARY STENTS MARKET, BY ABSORPTION RATE

       6.1. SLOW-ABSORPTION DES
       6.2. FAST-ABSORPTION (DES)

7. GLOBAL CORONARY STENTS MARKET, BY MATERIAL

       7.1. OVERVIEW
       7.2. STAINLESS STEEL
       7.3. COBALT ALLOY METAL
       7.4. GOLD
       7.5. TANTALUM
       7.6. NITINOL
        7.7. POLYMERS

8. GLOBAL CORONARY STENTS MARKET, BY RATE

       8.1. OVERVIEW
       8.2. SLOW-ABSORPTION STENTS
       8.3. FAST-ABSORPTION STENTS

9. GLOBAL CORONARY STENTS MARKET, BY APPLICATION

       9.1. CORONARY ARTERY DISEASE
       9.2. PERIPHERAL ARTERY DISEASE

10. GLOBAL CORONARY STENTS MARKET, BY END USER

       10.1. HOSPITALS
       10.2. CARDIAC CENTERS
       10.3. OTHERS

11. GLOBAL CORONARY STENTS MARKET, BY GEOGRAPHY

       11.1. COUNTRYWISE CORONARY STENTS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
                11.1.1. NORTH AMERICA
                            11.1.1.1. U.S.
                            11.1.1.2. CANADA
                            11.1.1.3. MEXICO
                11.1.2. EUROPE
                            11.1.2.1. GERMANY
                            11.1.2.2. FRANCE
                            11.1.2.3. U.K.
                            11.1.2.4. ITALY
                            11.1.2.5. SPAIN
                            11.1.2.6. RUSSIA
                            11.1.2.7. TURKEY
                            11.1.2.8. BELGIUM
                            11.1.2.9. NETHERLANDS
                            11.1.2.10. SWITZERLAND
                            11.1.2.11. REST OF EUROPE
                11.1.3. ASIA-PACIFIC (APAC)
                            11.1.3.1. JAPAN
                            11.1.3.2. CHINA
                            11.1.3.3. SOUTH KOREA
                            11.1.3.4. INDIA
                            11.1.3.5. AUSTRALIA
                            11.1.3.6. SINGAPORE
                            11.1.3.7. THAILAND
                            11.1.3.8. MALAYSIA
                            11.1.3.9. INDONESIA
                            11.1.3.10. PHILIPPINES
                            11.1.3.11. REST OF APAC
                11.1.4. SOUTH AMERICA
                            11.1.4.1. BRAZIL
                            11.1.4.2. REST OF SOUTH AMERICA
                11.1.5. MIDDLE EAST AND AFRICA
                            11.1.5.1. SOUTH AFRICA
                            11.1.5.2. REST OF MIDDLE EAST AND AFRICA
       11.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

12. GLOBAL CORONARY STENTS MARKET: COMPETITIVE LANDSCAPE

       12.1. GLOBAL CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
       12.2. U.S. CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
       12.3. EUROPE CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
       12.4. APAC CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
       12.5. SOUTH AMERICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
       12.6. MIDDLE EAST AND AFRICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
       12.7. MERGERS & ACQUISITIONS
       12.8. NEW PRODUCT DEVELOPMENT & APPROVALS
       12.9. EXPANSIONS
       12.10. REGULATORY CHANGES
       12.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS            

13. GLOBAL CORONARY STENTS MARKET, COMPANY PROFILES

       13.1. ABBOTT VASCULAR
                13.1.1. OVERVIEW
                13.1.2. SWOT ANALYSIS
                13.1.3. PRODUCT PORTFOLIO
                13.1.4. REVENUE ANALYSIS
                13.1.5. ANALYSTS VIEW
       13.2. SCITECH
                13.2.1. OVERVIEW
                13.2.2. SWOT ANALYSIS
                13.2.3. PRODUCT PORTFOLIO
                13.2.4. REVENUE ANALYSIS
                13.2.5. ANALYSTS VIEW
       13.3. BOSTON SCIENTIFIC CORPORATION
                13.3.1. OVERVIEW
                13.3.2. SWOT ANALYSIS
                13.3.3. PRODUCT PORTFOLIO
                13.3.4. REVENUE ANALYSIS
                13.3.5. ANALYST VIEW
       13.4. MEDINOL LTD
                13.4.1. OVERVIEW
                13.4.2. SWOT ANALYSIS
                13.4.3. PRODUCT PORTFOLIO
                13.4.4. REVENUE ANALYSIS
                13.4.5. ANALYSTS VIEW
       13.5. IVASCULAR SLU
                13.5.1. OVERVIEW
                13.5.2. SWOT ANALYSIS
                13.5.3. PRODUCT PORTFOLIO
                13.5.4. REVENUE ANALYSIS
               13.5.5. ANALYSTS VIEW
       13.6. STENTYS SA
                13.6.1. OVERVIEW
                13.6.2. SWOT ANALYSIS
                13.6.3. PRODUCT PORTFOLIO
                13.6.4. REVENUE ANALYSIS
                13.6.5. ANALYSTS VIEW
       13.7. ELIXIR MEDICAL CORPORATION
                13.7.1. OVERVIEW
                13.7.2. SWOT ANALYSIS
                13.7.3. PRODUCT PORTFOLIO
                13.7.4. REVENUE ANALYSIS
                13.7.5. ANALYSTS VIEW
       13.8. INSPIRE MD
                13.8.1. OVERVIEW
                13.8.2. SWOT ANALYSIS
                13.8.3. PRODUCT PORTFOLIO
                13.8.4. REVENUE ANALYSIS
                13.8.5. ANALYSTS VIEW
       13.9. HEXACATH
                13.9.1. OVERVIEW
                13.9.2. SWOT ANALYSIS
                13.9.3. PRODUCT PORTFOLIO
                13.9.4. REVENUE ANALYSIS
                13.9.5. ANALYSTS VIEW
       13.10. MEDTRONIC
                13.10.1. OVERVIEW
                13.10.2. SWOT ANALYSIS
                13.10.3. PRODUCT PORTFOLIO
                13.10.4. REVENUE ANALYSIS
                13.10.5. ANALYSTS VIEW
       13.11. ORBUSNEICH
                13.11.1. OVERVIEW
                13.11.2. SWOT ANALYSIS
                13.11.3   PRODUCT PORTFOLIO
                13.11.4   REVENUE ANALYSIS
                13.11.5   ANALYSTS VIEW
       13.12. ANDRAMED GMBH
                13.12.1. OVERVIEW
                13.12.2. SWOT ANALYSIS
                13.12.3. PRODUCT PORTFOLIO
                13.12.4. REVENUE ANALYSIS
                13.12.5. ANALYSTS VIEW
       13.13. CORDIS CORPORATION
                13.13.1. OVERVIEW
                13.13.2. SWOT ANALYSIS
                13.13.3. PRODUCT PORTFOLIO
                13.13.4. REVENUE ANALYSIS
                13.13.5. ANALYSTS VIEW
       13.14. ENDOCOR GMBH
                13.14.1. OVERVIEW
                13.14.2. SWOT ANALYSIS
                13.14.3. PRODUCT PORTFOLIO
                13.14.4. REVENUE ANALYSIS
                13.14.5. ANALYSTS VIEW
       13.15. EUROCOR GMBH
                13.15.1. OVERVIEW
                13.15.2. SWOT ANALYSIS
                13.15.3. PRODUCT PORTFOLIO
                13.15.4. REVENUE ANALYSIS
                13.15.5. ANALYSTS VIEW
       13.16. COOK MEDICAL.
                13.16.1. OVERVIEW
                13.16.2. SWOT ANALYSIS
                13.16.3. PRODUCT PORTFOLIO
                13.16.4. REVENUE ANALYSIS
                13.16.5. ANALYSTS VIEW
       13.17. MICROPORT SCIENTIFIC CORPORATION
                13.17.1. OVERVIEW
                13.17.2. SWOT ANALYSIS
                13.17.3. PRODUCT PORTFOLIO
                13.17.4. REVENUE ANALYSIS
                13.17.5. ANALYSTS VIEW
       13.18. DEGANIA SILICONE LTD.
                13.18.1. OVERVIEW
                13.18.2. SWOT ANALYSIS
                13.18.3. PRODUCT PORTFOLIO
                13.18.4. REVENUE ANALYSIS
                13.18.5. ANALYSTS VIEW
       13.19. TERUMO CORPORATION
                13.19.1. OVERVIEW
                13.19.2. SWOT ANALYSIS
                13.19.3. PRODUCT PORTFOLIO
                13.19.4. REVENUE ANALYSIS
                13.19.5. ANALYSTS VIEW
       13.20. MERIL LIFE SCIENCES PVT. LTD.
                13.20.1. OVERVIEW
                13.20.2. SWOT ANALYSIS
                13.20.3. PRODUCT PORTFOLIO
                13.20.4. REVENUE ANALYSIS
                13.20.5. ANALYSTS VIEW
       13.21. ALVIMEDICA
                13.21.1. OVERVIEW
                13.21.2. SWOT ANALYSIS
                13.21.3. PRODUCT PORTFOLIO
                13.21.4. REVENUE ANALYSIS
                13.21.5. ANALYSTS VIEW
       13.22. ELIXIR MEDICAL CORPORATION
                13.22.1. OVERVIEW
                13.22.2. SWOT ANALYSIS
                13.22.3. PRODUCT PORTFOLIO
                13.22.4. REVENUE ANALYSIS
                13.22.5. ANALYSTS VIEW
       13.23. INSITU TECHNOLOGIES INC.
                13.23.1. OVERVIEW
                13.23.2. SWOT ANALYSIS
                13.23.3. PRODUCT PORTFOLIO
                13.23.4. REVENUE ANALYSIS
                13.23.5. ANALYSTS VIEW
       13.24. BIOTRONIK SE & CO. KG
                13.24.1. OVERVIEW
                13.24.2. SWOT ANALYSIS
                13.24.3. PRODUCT PORTFOLIO
                13.24.4. REVENUE ANALYSIS
                13.24.5. ANALYSTS VIEW
       13.25. AMG INTERNATIONAL GMBH
                13.25.1. OVERVIEW
                13.25.2. SWOT ANALYSIS
                13.25.3. PRODUCT PORTFOLIO
                13.25.4. REVENUE ANALYSIS
                13.25.5. ANALYSTS VIEW
       13.26. ARTHESYS
                13.26.1. OVERVIEW
                13.26.2. SWOT ANALYSIS
                13.26.3. PRODUCT PORTFOLIO
                13.26.4. REVENUE ANALYSIS
                13.26.5. ANALYSTS VIEW
       13.27. TRANSLUMINA GMBH
                13.27.1. OVERVIEW
                13.27.2. SWOT ANALYSIS
                13.27.3. PRODUCT PORTFOLIO
                13.27.4. REVENUE ANALYSIS
                13.27.5. ANALYSTS VIEW
       13.28. LEPU MEDICAL
                13.28.1. OVERVIEW
                13.28.2. SWOT ANALYSIS
                13.28.3. PRODUCT PORTFOLIO
                13.28.4. REVENUE ANALYSIS
                13.28.5. ANALYSTS VIEW
       13.29. ACCURA
                13.29.1. OVERVIEW
                13.29.2. SWOT ANALYSIS
                13.29.3. PRODUCT PORTFOLIO
                13.29.4. REVENUE ANALYSIS
                13.29.5. ANALYSTS VIEW
       13.30. CELONOVA BIOSCIENCES, INC.
                13.30.1. OVERVIEW
                13.30.2. SWOT ANALYSIS
                13.30.3. PRODUCT PORTFOLIO
                13.30.4. REVENUE ANALYSIS
                13.30.5. ANALYSTS VIEW
       13.31. MINVASYS
                13.31.1. OVERVIEW
                13.31.2. SWOT ANALYSIS
                13.31.3. PRODUCT PORTFOLIO
                13.31.4. REVENUE ANALYSIS
                13.31.5. ANALYSTS VIEW
       13.32. SVELTE MEDICAL
                13.32.1. OVERVIEW
                13.32.2. SWOT ANALYSIS
                13.32.3. PRODUCT PORTFOLIO
                13.32.4. REVENUE ANALYSIS
                13.32.5. ANALYSTS VIEW
       13.33. B. BRAUN MELSUNGEN AG
                13.33.1. OVERVIEW
                13.33.2. SWOT ANALYSIS
                13.33.3. PRODUCT PORTFOLIO
                13.33.4. REVENUE ANALYSIS
                13.33.5. ANALYSTS VIEW
       13.34. EUCATECH AG
                13.34.1. OVERVIEW
                13.34.2. SWOT ANALYSIS
                13.34.3. PRODUCT PORTFOLIO
                13.34.4. REVENUE ANALYSIS
                13.34.5. ANALYSTS VIEW

13. APPENDIX

14. ABOUT DATA BRIDGE MARKET RESEARCH

List of Table

Please fill in the below form for detailed List of Table

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Figure

Please fill in the below form for detailed List of Figure

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

View Infographics

Please fill in the below form for detailed Infographics

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country
CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3200.00
  • 8000.00
  • 15000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19